Skip to content
Nidan Labs & Healthcare logo

Nidan Labs & Healthcare

NIDAN NSE
₹13.00 unchanged 0.00 (0.00%)
Market Cap
₹18.07 Cr
P/E
4.48

Nidan Labs & Healthcare (NIDAN) share price was ₹13.00 at the 27 Oct 2026 close; market capitalisation ₹18.07 Cr; P/E (TTM) 4.48; sector Healthcare Services. The share price fell 31.2% over the year to 27 Oct 2026 (adjusted for splits and bonuses). In the Mar 2026 quarter, revenue fell 11.2% year on year to ₹12.42 Cr and net profit fell 92.1% year on year to ₹0.07 Cr (compared with Mar 2025). Promoters held 57.04% of Nidan Labs & Healthcare in Jun 2026, unchanged from Mar 2026. Its Tapetide Score is 57/100 (Good) as of 28 Oct 2026.

Close 27 Oct 2026 ₹13.00 −5.85 −31.03% 1Y

Key Fundamentals

SMEHealthcare ServicesHealthcare
Market Cap
₹18.07 Cr
P/E (TTM)
4.48
EBITDA
₹6.70 Cr
Return on Equity
2.16%
Debt to Equity
0.16
Book Value
₹50.14
EPS (TTM)
₹2.90
52W High
₹24.90
52W Low
₹11.50

Price-based figures as of 29 Oct 2026, 09:59 IST · TTM

Peer Comparison

Healthcare › Healthcare Services › Healthcare Service Provider

Dr Lal Pathlabs
₹1,906.9058.9632,007 Cr12.760.26%20.06%25.67%2,996 Cr545 Cr
Vijaya Diagnostic Centre
₹1,439.0078.9414,821 Cr15.480.14%18.07%19.22%879 Cr187 Cr
Metropolis Healthcare
₹549.1056.4311,388 Cr7.580.91%12.54%15.73%1,733 Cr203 Cr
Thyrocare Technologies
₹514.6046.448,191 Cr15.982.84%27.79%33.84%894 Cr176 Cr
Nephrocare Health Services
₹630.30150.436,338 Cr5.680.00%6.88%13.46%1,079 Cr85 Cr
Suraksha Diagnostic
₹318.5546.301,659 Cr6.780.16%12.90%14.70%329 Cr35 Cr
Krsnaa Diagnostics
₹497.0016.301,612 Cr1.640.40%10.35%10.64%862 Cr98 Cr
Nidan Labs & Healthcare (this company)
₹13.004.4818 Cr0.260.00%2.16%5.96%24 Cr3 Cr
Median 8 companies₹531.8551.447,264 Cr7.180.21%12.72%15.22%887 Cr137 Cr

Comparable companies in the same industry. Market cap, P/E and P/B use the live price; other metrics are as reported in filings. A dash means the figure is not published for that company.

Tapetide Score

Data-driven rating, 0–100, as of . How it works →

57 Good
Overall score

Data confidence 100/100

Category scores

Quality Good 59
Returns, margins, earnings quality 22% weight
Valuation Strong 81
Cheap vs sector & own history 24% weight
Growth Weak 43
Sales & profit trajectory 9% weight
Financial Health Average 47
Solvency, leverage, coverage 9% weight
Momentum Poor 34
Trend strength, vol-adjusted 12% weight
Ownership Average 50
FII/DII/promoter flows 24% weight

The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.

Key Insights

Strengths

2
  • Stock is trading at 0.25 times its book value
  • Company's working capital requirements have reduced from 87.8 days to 33.6 days

Weaknesses

4
  • Though the company is reporting repeated profits, it is not paying out dividend
  • The company has delivered a poor sales growth of 4.62% over past five years.
  • Company has a low return on equity of 1.81% over last 3 years.
  • Promoter holding has decreased over last 3 years: -5.75%

Technical Indicators

Oscillators

Bearish

Bearish
2
Neutral
7
Bullish
0

Overall

Bearish

Bearish
10
Neutral
7
Bullish
2

Moving Averages

Bearish

Bearish
8
Neutral
0
Bullish
2

Growth Rate

Revenue Growth
2.24% higher than 3Y

change over 1 year

Net Income Growth
-25% lower than 3Y

change over 1 year

Cash Flow Change
-29.24%

change over 1 year

EBITDA Margin Change
-10.47%

change over 1 year Operating margin 18.52% · Mar 2026

Quarterly Results

Particulars Mar 2022Sep 2022Mar 2023Sep 2023Mar 2024Sep 2024Mar 2025Sep 2025Mar 2026
Sales
13.14
14.09
10.18
11.82
12.35
10.53
13.99
13.12
12.42
Expenses
9.52
8.93
8.54
8.48
9.24
7.93
11.53
10.58
10.12
Operating Profit
3.62
5.16
1.64
3.34
3.11
2.6
2.46
2.54
2.3
OPM %
27.55%
36.62%
16.11%
28.26%
25.18%
24.69%
17.58%
19.36%
18.52%
Other Income
0.39
0.33
3
1.52
-5.29
1.03
1.22
1.17
0.29
Interest
0.95
1.03
1.19
0.98
1.2
0.88
1.26
0.88
1.07
Depreciation
0.87
1.44
1.66
1.28
1.59
1.34
1.07
0.92
0.98
PBT
2.19
3.02
1.79
2.6
-4.97
1.41
1.35
1.91
0.54
Tax %
61.19%
23.51%
31.28%
26.15%
3.62%
21.99%
34.81%
24.61%
87.04%
Net Profit
0.86
2.32
1.22
1.92
-5.15
1.1
0.88
1.43
0.07
EPS (₹)
0.62
1.67
0.88
1.38
-3.71
0.79
0.63
1.03
0.05
Figures in ₹ Crores

Profit & Loss

Particulars Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Sales
20.07
21.41
20.38
29.66
24.27
24.18
24.53
25.54
Expenses
12.23
13.78
11.49
20.25
17.47
17.74
19.47
20.7
Operating Profit
7.84
7.63
8.89
9.41
6.8
6.44
5.06
4.84
OPM %
39.06%
35.64%
43.62%
31.73%
28.02%
26.63%
20.63%
18.95%
Other Income
0.37
0.01
1.06
0.4
3.33
-3.76
2.25
1.46
Interest
4.75
3.74
3.46
2.66
2.22
2.18
2.14
1.96
Depreciation
3.24
3.19
3.18
2.63
3.1
2.87
2.41
1.9
PBT
0.22
0.71
3.31
4.52
4.81
-2.37
2.76
2.44
Tax %
0%
0%
30.21%
41.15%
26.4%
36.29%
28.26%
38.11%
Net Profit
0.22
0.71
2.3
2.66
3.54
-3.23
1.98
1.51
EPS (₹)
0.22
0.72
2.32
1.91
2.55
-2.32
1.42
1.09
Div. Payout %
0%
0%
0%
0%
0%
0%
0%
0%
Figures in ₹ Crores

Balance Sheet

Particulars Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
9.9
9.9
9.9
13.9
13.9
13.9
13.9
13.9
Reserves
0.41
1.13
3.43
52
55.54
52.31
54.28
55.79
Borrowings
32.16
34.35
38.04
19.29
10.93
12.44
11.11
11.17
Other Liabilities
0.58
-0.17
2.37
3.29
4.03
3.9
3.65
3.14
Total Liabilities
43.05
45.21
53.74
88.48
84.4
82.55
82.94
84
Fixed Assets
23.28
20.1
19.92
20.46
21.39
17.95
16.33
14.91
CWIP
0
0
0.23
3.81
0
0.04
0.15
0.15
Investments
0.53
0.53
0.27
0
0
0
20
20
Other Assets
19.24
24.58
33.32
64.21
63.01
64.56
46.46
48.94
Total Assets
43.05
45.21
53.74
88.48
84.4
82.55
82.94
84
Figures in ₹ Crores

Cash Flow

Particulars Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
8.95
4.62
4.35
7.83
10.97
5.52
2.36
1.67
Investing
1
-0.01
-3.22
-35.74
-0.29
-10.6
-0.21
0.06
Financing
-5.81
-1.56
-1.22
28.72
-10.37
-0.49
-3.1
-1.63
Net Cash Flow
4.14
3.05
-0.1
0.8
0.32
-5.57
-0.95
0.1
Free Cash Flow
9.95
4.61
1.13
1.36
11.02
4.88
1.49
1.19
CFO/OP
114
61
49
96
162
129
78
55
Figures in ₹ Crores

Ratios

Particulars Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
102
92.57
97.25
65.96
90.69
7.85
18.9
31.73
Inventory Days
16.98
12.88
18.17
25.99
—
—
—
—
Days Payable
117
—
213
136
—
—
—
—
Cash Conversion Cycle
2.29
—
-97.64
-43.89
90.69
7.85
18.9
31.73
Working Capital Days
256
292
-189
54.52
43.46
243
-13.39
33.58
ROCE %
—
10.13%
13.99%
10.09%
8.17%
7.95%
6.17%
5.99%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Nidan Labs & Healthcare insights

56 extracted metrics + investor summaries across FY19–FY26.

Shareholding Pattern

Promot.57.04%Others3.02%Public39.94%As ofJun 2026

Documents

Frequently Asked Questions about Nidan Labs & Healthcare

What does Nidan Laboratories & Healthcare Ltd do?
Incorporated in 2000, Nidan Laboratories & Healthcare Ltd is in the business of providing various Healthcare and Diagnostics Services[1]
Where is Nidan Laboratories & Healthcare Ltd (NIDAN) listed?
Nidan Laboratories & Healthcare Ltd trades as NIDAN on the NSE.
Which sector does Nidan Laboratories & Healthcare Ltd belong to?
Nidan Laboratories & Healthcare Ltd is classified under the Healthcare Services sector, in the Healthcare Service Provider industry.
What is the market capitalisation of Nidan Laboratories & Healthcare Ltd?
Nidan Laboratories & Healthcare Ltd has a market capitalisation of ₹18.07 Cr as of 29 Oct 2026, which places it in the Small Cap band.
What is the PE ratio of Nidan Laboratories & Healthcare Ltd?
Nidan Laboratories & Healthcare Ltd trades at a PE ratio of 4.48 as of 29 Oct 2026, on earnings per share of ₹2.9, against a book value of ₹50.14 per share.
What is the 52-week high and low of Nidan Laboratories & Healthcare Ltd?
Over the last 52 weeks Nidan Laboratories & Healthcare Ltd has traded between ₹11.5 and ₹24.9 as of 29 Oct 2026.
What is the Return on Equity (ROE) of Nidan Laboratories & Healthcare Ltd?
Nidan Laboratories & Healthcare Ltd reported a return on equity of 2.16%. Its debt-to-equity ratio is 0.16.

Company Information

Incorporated in 2000, Nidan Laboratories & Healthcare Ltd is in the business of providing various Healthcare and Diagnostics Services[1]

Website nidanhealthcare.co.in
Listed 2021-11-12
Face Value ₹ 10
Shares Outstanding 1,39,00,000

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/NIDAN.md for Nidan Laboratories & Healthcare Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our Indian stock market MCP server.

Explore More

More Hospital & Healthcare Services stocks → FII DII DataStock ScreenerNifty 50 HeatmapF&O Ban ListFII and DII flows, month by monthHow Tapetide Scores changed, month by monthStocks mutual funds are buying, month by month